Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $36.39 Analyst target: $33.57 Upside: -7.75%
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United States. The company is headquartered in Parsippany, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.